Financial statements Bio-Gen
Balance sheet data of BIO-GEN
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 3 713 258,57 | 7 385 557,09 | 11 503 096,75 | 17 189 021,00 | 42 332 620,06 | 53 451 312,18 |
| A. Fixed assets | 1 425 135,07 | 1 592 076,75 | 3 252 813,19 | 4 296 328,37 | 11 349 182,47 | 19 062 271,65 |
| B. Current assets | 2 288 123,50 | 5 793 480,34 | 8 250 283,56 | 12 892 692,63 | 30 983 437,59 | 34 389 040,53 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 3 713 258,57 | 7 385 557,09 | 11 503 096,75 | 17 189 021,00 | 42 332 620,06 | 53 451 312,18 |
| A. Equity | 2 789 311,45 | 5 676 716,23 | 9 200 739,94 | 14 849 576,78 | 33 082 272,24 | 41 007 468,12 |
| B. Liabilities and provisions for liabilities | 923 947,12 | 1 708 840,86 | 2 302 356,81 | 2 339 444,22 | 9 250 347,82 | 12 443 844,06 |
| I. Long-term liabilities | 570 000,00 | 570 000,00 | 570 000,00 | 570 000,00 | 5 468 860,00 | 612 488,08 |
| II. Short-term liabilities | 353 947,12 | 1 137 698,36 | 1 683 669,23 | 1 765 838,30 | 3 781 487,82 | 11 177 534,80 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.